These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29701932)

  • 1. Tardive Dyskinesia: Is Vitamin E Singing the Prostate Blues?
    Deardorff OG; Burns NA; Hunter DR
    Prim Care Companion CNS Disord; 2018 Apr; 20(2):. PubMed ID: 29701932
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin E and prostate cancer: research focus turns to biologic mechanisms.
    McNeil C
    J Natl Cancer Inst; 2011 Dec; 103(23):1731-4. PubMed ID: 22100581
    [No Abstract]   [Full Text] [Related]  

  • 3. On call. In the May 2014 issue, you reported on findings from the Selenium and Vitamin E Cancer Prevention Trial (SELECT), which said that taking vitamin E and selenium raises the risk of prostate cancer. My multivitamin contains both of these nutrients. Should I worry?
    Kormos W
    Harv Mens Health Watch; 2014 Aug; 19(1):2. PubMed ID: 25306579
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitamin E in the treatment of tardive dyskinesia: a meta-analysis.
    Xu H; Qin H; Chen S; Guan M
    Int Clin Psychopharmacol; 2022 Mar; 37(2):60-66. PubMed ID: 35045531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E and prostate cancer.
    Chew EY; Clemons T
    Ophthalmology; 2012 Sep; 119(9):1938-9. PubMed ID: 22944498
    [No Abstract]   [Full Text] [Related]  

  • 6. KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
    Hauser RA; Factor SA; Marder SR; Knesevich MA; Ramirez PM; Jimenez R; Burke J; Liang GS; O'Brien CF
    Am J Psychiatry; 2017 May; 174(5):476-484. PubMed ID: 28320223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer: new data on risks of selenium and vitamin E.
    Payton S
    Nat Rev Urol; 2014 Apr; 11(4):184. PubMed ID: 24619375
    [No Abstract]   [Full Text] [Related]  

  • 8. Baseline selenium and prostate cancer risk: comments and open questions.
    Frankel PH; Parker RS; Madsen FC; Whanger PD
    J Natl Cancer Inst; 2014 Mar; 106(3):dju005. PubMed ID: 24563520
    [No Abstract]   [Full Text] [Related]  

  • 9. Ginkgo biloba and vitamin E ameliorate haloperidol-induced vacuous chewingmovement and brain-derived neurotrophic factor expression in a rat tardive dyskinesia model.
    Shi J; Tan YL; Wang ZR; An HM; Li J; Wang YC; Lv MH; Yan SX; Wu JQ; Soares JC; Yang FD; Zhang XY
    Pharmacol Biochem Behav; 2016 Sep; 148():53-8. PubMed ID: 27264436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidants for the Treatment of Tardive Dyskinesia: AIMing to Find the Best Treatment Option.
    Deardorff OG; Ehrhard KA; Cafer J; Hall BM
    Prim Care Companion CNS Disord; 2019 May; 21(3):. PubMed ID: 31087824
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancer risk and vitamin E.
    Hoskote SS; Nadkarni GN; Fried ED
    JAMA; 2012 Feb; 307(5):454; author reply 454. PubMed ID: 22298668
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostate cancer risk and vitamin E.
    Gaby AR
    JAMA; 2012 Feb; 307(5):453-4; author reply 454. PubMed ID: 22298667
    [No Abstract]   [Full Text] [Related]  

  • 13. Complementary therapies, herbs, and other OTC agents: vitamin E.
    Cassileth B
    Oncology (Williston Park); 2010 Jun; 24(7):661. PubMed ID: 20669806
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2.
    Pham DQ; Plakogiannis R
    Ann Pharmacother; 2005 Dec; 39(12):2065-72. PubMed ID: 16288072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patients.
    Witter DP; Holbert RC; Suryadevara U
    Expert Opin Pharmacother; 2017 Jul; 18(10):965-972. PubMed ID: 28443349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial.
    Goodman PJ; Tangen CM; Darke AK; Arnold KB; Hartline J; Yee M; Anderson K; Caban-Holt A; Christen WG; Cassano PA; Lance P; Klein EA; Crowley JJ; Minasian LM; Meyskens FL
    Trials; 2016 Aug; 17():400. PubMed ID: 27519183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin E. Assessing the risks and benefits.
    Mayo Clin Womens Healthsource; 2006 Mar; 10(3):1-2. PubMed ID: 16489282
    [No Abstract]   [Full Text] [Related]  

  • 18. Vitamin E supplementation: what's the harm in that?
    Miller ER; Guallar E
    Clin Trials; 2009 Feb; 6(1):47-9; discussion 50-1. PubMed ID: 19254933
    [No Abstract]   [Full Text] [Related]  

  • 19. On the opinion of the European Commission "Scientific Committee on Food" regarding the tolerable upper intake level of vitamin E (2003).
    Azzi A; Brigelius-Flohé R; Kelly F; Lodge JK; Ozer N; Packer L; Sies H
    Eur J Nutr; 2005 Feb; 44(1):60-2. PubMed ID: 15647855
    [No Abstract]   [Full Text] [Related]  

  • 20. Vitamin E supplements: helpful or harmful?
    Drown DJ
    Prog Cardiovasc Nurs; 2005; 20(1):38-9. PubMed ID: 15785169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.